Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
0.9152
Dollar change
+0.0152
Percentage change
1.69
%
IndexRUT P/E- EPS (ttm)-0.80 Insider Own55.21% Shs Outstand256.56M Perf Week-2.49%
Market Cap267.39M Forward P/E- EPS next Y-0.83 Insider Trans0.00% Shs Float130.85M Perf Month-24.98%
Income-203.99M PEG- EPS next Q-0.19 Inst Own21.59% Short Float7.34% Perf Quarter-20.42%
Sales0.06M P/S4456.52 EPS this Y14.52% Inst Trans0.13% Short Ratio7.40 Perf Half Y-63.54%
Book/sh2.07 P/B0.44 EPS next Y-4.09% ROA-28.85% Short Interest9.60M Perf Year-52.33%
Cash/sh1.51 P/C0.61 EPS next 5Y-7.90% ROE-33.22% 52W Range0.85 - 3.26 Perf YTD-52.82%
Dividend Est.- P/FCF- EPS past 5Y-15.28% ROI-35.04% 52W High-71.89% Beta-0.46
Dividend TTM- Quick Ratio13.43 Sales past 5Y428.28% Gross Margin-31109.52% 52W Low7.67% ATR (14)0.10
Dividend Ex-Date- Current Ratio13.43 EPS Y/Y TTM-5.45% Oper. Margin-350066.67% RSI (14)40.60 Volatility6.01% 9.65%
Employees224 Debt/Eq0.11 Sales Y/Y TTM-99.87% Profit Margin-323792.06% Recom3.33 Target Price1.00
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q14.08% Payout- Rel Volume0.85 Prev Close0.90
Sales Surprise- EPS Surprise12.82% Sales Q/Q36.00% EarningsNov 07 AMC Avg Volume1.30M Price0.92
SMA20-7.57% SMA50-15.56% SMA200-48.01% Trades Volume1,100,442 Change1.69%
Date Action Analyst Rating Change Price Target Change
Oct-30-24Downgrade BofA Securities Buy → Underperform $6 → $1
Jun-27-24Downgrade H.C. Wainwright Buy → Neutral $6 → $1
Aug-28-23Downgrade JP Morgan Overweight → Neutral $15 → $5
Nov-14-22Downgrade Morgan Stanley Overweight → Equal-Weight $15 → $7
Nov-11-22Downgrade Goldman Buy → Neutral $13 → $7
Oct-17-22Initiated H.C. Wainwright Buy $12
Jul-12-21Initiated Morgan Stanley Overweight $25
Jul-12-21Initiated JP Morgan Overweight $22
Jul-12-21Initiated Goldman Buy $30
Jul-12-21Initiated BofA Securities Buy $25
Dec-09-24 09:00PM
Nov-14-24 12:00PM
Nov-07-24 05:22PM
04:05PM
Nov-05-24 09:30AM
04:00PM Loading…
Oct-31-24 04:00PM
Oct-30-24 11:16AM
Oct-25-24 11:56AM
Oct-24-24 04:00PM
01:54PM
Oct-04-24 09:00AM
Sep-24-24 04:05PM
Aug-28-24 04:05PM
Aug-07-24 05:41PM
04:05PM
08:00AM Loading…
Aug-06-24 08:00AM
Jun-26-24 02:44PM
07:00AM
Jun-03-24 04:05PM
May-07-24 04:05PM
May-06-24 10:53PM
01:34PM
08:23AM
08:00AM
Mar-19-24 10:00AM
Mar-07-24 12:00PM
Mar-05-24 04:30PM
Feb-28-24 04:44PM
04:05PM
Feb-26-24 04:05PM
04:05PM Loading…
Jan-03-24 04:05PM
Nov-09-23 04:05PM
Nov-07-23 04:33PM
04:05PM
Oct-31-23 09:00AM
Sep-27-23 09:00AM
Sep-11-23 08:00AM
Aug-31-23 04:05PM
Aug-08-23 07:10PM
04:05PM
Jul-12-23 08:47AM
Jul-05-23 04:05PM
Jun-16-23 10:47AM
Jun-07-23 04:05PM
Jun-01-23 07:55AM
May-04-23 07:25PM
06:25PM
04:05PM
May-02-23 04:05PM
Apr-17-23 07:11AM
Mar-27-23 04:52AM
Mar-26-23 10:14AM
Feb-28-23 08:15PM
04:05PM
Feb-02-23 06:43AM
Jan-03-23 04:05PM
Dec-23-22 06:36AM
Dec-16-22 10:48AM
Dec-15-22 07:00AM
Dec-09-22 09:35AM
Dec-01-22 04:05PM
Nov-12-22 07:39AM
Nov-10-22 04:05PM
06:24AM
Nov-08-22 07:15PM
04:05PM
Nov-07-22 08:05AM
Nov-04-22 10:00AM
Nov-02-22 04:05PM
Oct-25-22 07:59AM
Oct-17-22 12:54PM
09:28AM
Oct-06-22 04:05PM
Oct-05-22 08:05AM
Sep-28-22 04:05PM
Sep-15-22 09:40AM
Sep-12-22 09:55AM
03:00AM
Aug-30-22 04:05PM
Aug-26-22 09:55AM
Aug-10-22 09:55AM
Aug-08-22 06:30AM
Aug-04-22 06:25PM
04:05PM
Jul-17-22 09:49AM
Jun-30-22 01:08PM
Jun-17-22 07:38AM
Jun-07-22 04:05PM
May-25-22 03:00PM
May-10-22 04:05PM
10:45AM
May-09-22 11:29AM
May-05-22 09:31AM
May-04-22 04:05PM
10:52AM
May-03-22 09:55AM
May-02-22 04:30PM
Mar-29-22 04:05PM
Mar-20-22 08:02AM
Mar-16-22 06:26AM
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.